Stryker Corporation

SYK trades at a P/E of 33.8, nearly double the surgical instruments sector median, yet its RSI of 21.4 signals deeply oversold conditions—a rare disconnect suggesting either severe pessimism or valuation disconnect. The 1.29% short interest rules out squeeze dynamics, while the stock sits below its 52-week high despite being a $129.9B market cap leader. This setup presents an unusual tension: the elevated multiple typically demands growth confidence that the oversold RSI contradicts, implying either a brutal recent selloff or structural concerns about earnings sustainability that haven't yet reflected in the valuation multiple.